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Preface 
This dissertation is part of a PhD carried out at the University of Bergen at the 
Department of Informatics from the beginning of 2006 through to the end of 2009. 
The period also included a minor stay at the European Bioinformatics Institute in 
Hinxton, UK, and several trips abroad to international conferences and meetings. In 
addition to the scientific research, the PhD fellowship also included 25% teaching 
duties spread throughout the four years. 
 
Serendipity 
Serendipity seems to be a common feature both in life and in science. Here are three 
brief examples from my time in science so far. First off, I never planned to study 
bioinformatics. My plan was to become a biologist. But after realizing that one had to 
spend a lot of time doing tedious lab work and writing extensive amounts of lab 
reports before achieving this, I decided I would rather leave the University and 
become an engineer instead. However, I had to wait a semester before this plan 
could be set into action, and I needed something to pass the time. Somewhat 
randomly I ended up taking an introductory course in informatics.  
Fast forward 3.5 years. I’m now doing a Master in bioinformatics, and a couple of 
‘summer jobs’ at the Department of Informatics are advertised. I apply, resulting in 
the development of a tool for analyzing mass spectrometry data, and as a 
consequence, the original plans for my Master thesis are replaced by additional work 
on this mass spectrometry tool.  
Fast forward again, this time around 3 years. I’m now in the middle of my PhD, still 
working on mass spectrometry data analysis, and an opportunity to develop a system 
for making mass spectrometry data publicly available comes along. And something 
that was originally meant to be a three month assignment, ends up as a much more 
extensive project, becomes an important part of my PhD, and results in a publication 
in Nature Biotechnology. 
The bottom line seems to be that serendipity often ends up affecting even the best 
laid plans. And the trick seems to be to not get thrown off by this, but instead to try 
to make the best out of it. Given the above, this seems to have worked out pretty 
well for me so far. 
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Abbreviations 
1D, 2D, 3D  One-dimensional, Two-dimensional, Three-dimensional 
 
CAD   Collisionally Activated Dissociation 
CID   Collision Induced Dissociation 
CV   Controlled Vocabulary 
 
Da Dalton, the atomic mass unit, named after the chemist  
John Dalton 
de novo From the beginning, here used to describe the process of 
sequencing a peptide directly from the mass spectrum, i.e.,  
de novo sequencing 
DNA   DeoxyriboNucleic Acid 
 
ECD   Electron Capture Dissociation 
ESI   Electro-Spray Ionization 
ETD   Electron Transfer Dissociation 
 
GUI   Graphical User Interface 
 
HUPO   Human Proteome Organization 
HUPO-PSI  HUPO Proteomics Standards Initiative 
HPLC   High Pressure Liquid Chromatography 
 
in silico  Performed on computer or via computer simulation 
iTRAQ   Isobaric Tag for Relative and Absolute Quantization 
 
LC-MS   Liquid Chromatography Mass Spectrometry 
LIMS   Laboratory Information and Management System 
 
m/z  In a mass spectrum the horizontal axis represents the mass (m)  
of a molecule divided by its number of charges (z), m/z is often 
referred to as the mass to charge ratio 
MALDI  Matrix Assisted Laser Desorption and Ionization 
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MIAPE   Minimum Information About a Proteomics Experiment 
mRNA   Messenger RiboNucleic Acid 
MS    Mass Spectrometry 
MS/MS   Tandem Mass Spectrometry 
ms_lims Mass Spectrometry Laboratory Information and  
Management System 
 
OLS   Ontology Lookup Service 
OMSSA  the Open Mass Spectrometry Search Algorithm 
 
ppm   parts per million 
PRIDE   PRoteomics IDEntifications database 
ProDaC  Proteomics Data Collection, referring to the ProDaC initiative 
PSI   Proteomics Standards Initiative 
PTM   Post-Translational Modification 
 
Q-TOF   Quadrupole Time Of Flight 
 
RNA   RiboNucleic Acid 
RP   Reverse Phase 
RP-HPLC  Reverse Phase High Pressure Liquid Chromatography 
 
SAX   Strong Anion Exchange 
SCX   Strong Cation Exchange 
SILAC   Stable Isotope Labeling with Amino acids in Cell culture 
 
TOF   Time Of Flight 
 
XML   eXtensible Markup Language 
 
Contents vii 
 
 
 
 
Table of Contents 
1 Proteomics ............................................................................................................... 1 
1.1 What is Proteomics? ......................................................................................... 1 
1.2 Proteins and the Proteome ............................................................................... 2 
1.2.1 Protein Sequence Databases ...................................................................... 5 
1.3 Mass Spectrometry ........................................................................................... 6 
1.3.1 Protein Sample Preparation ....................................................................... 6 
1.3.2 Mass Spectrometry Instruments ................................................................ 8 
1.3.3 Peptide Fragmentation ............................................................................. 12 
1.4 Analyzing Mass Spectrometry Data ................................................................ 13 
1.4.1 Raw Spectra vs. Peak Lists ........................................................................ 13 
1.4.2 Protein and Peptide Identification ........................................................... 14 
1.4.3 Protein Characterization ........................................................................... 18 
1.4.4 Protein Quantification .............................................................................. 19 
1.5 Publicly Available Proteomics Data ................................................................. 20 
1.5.1 Data Formats ............................................................................................ 21 
1.5.2 Standards .................................................................................................. 22 
1.5.3 Converters and Viewers ........................................................................... 23 
2 Contributed Tools and Analyses ............................................................................ 25 
2.1 Peptide Mass Fingerprinting Data Analysis ..................................................... 25 
2.2 Protease-Dependent Fractional Mass and Peptide Properties ...................... 26 
2.3 Post-Translational Modifications and Amino Acid Substitutions ................... 26 
2.4 Analyzing MS/MS Fragmentation Data ........................................................... 27 
2.5 Making Proteomics Data Sharing Easy ............................................................ 28 
3 Contributing Papers ............................................................................................... 31 
3.1 List of Included Papers .................................................................................... 31 
4 Additional Work ..................................................................................................... 33 
4.1 List of Additional Papers .................................................................................. 33 
4.2 Web Resources ................................................................................................ 35 
viii Contents 
 
 
 
 
5 Discussion and Future Directions ........................................................................... 37 
5.1 User Interface Design ...................................................................................... 37 
5.2 Enabling and Empowering Users ..................................................................... 39 
5.2.1 Converting and Annotating Data .............................................................. 40 
5.2.2 Analyzing Complex Data Sets ................................................................... 42 
5.3 Open Source Software .................................................................................... 43 
5.4 Future Directions ............................................................................................. 45 
5.4.1 Standardized and Open Access Proteomics ............................................. 45 
5.4.2 Improved Protein Quantification ............................................................. 46 
5.4.3 Integrative Omics Research ...................................................................... 47 
6 References .............................................................................................................. 49 
 
 
List of Figures 
Figure 1: Schematic illustration of the central dogma of molecular biology ................. 2 
Figure 2: Schematic illustration of a mass spectrum ...................................................... 9 
Figure 3: Illustration of the standard fragment ions .................................................... 13 
Figure 4: The process of protein identification via MS spectra .................................... 15 
Figure 5: The process of peptide and protein identification via MS/MS spectra ........ 16 
Figure 6: An overview of the number of PRIDE experiments ....................................... 42 
 
 
List of Tables 
Table 1: Listing of the 20 standard amino acids ............................................................. 3 
Table 2: An overview of the standard genetic code ....................................................... 4 
Proteomics 1 
 
 
 
 
1 Proteomics 
The topic of this thesis is proteomics. Before getting into the details of the 
contributions made to this field, a general introduction to the field of proteomics will 
be provided. The following is not intended to be a complete coverage of all areas of 
proteomics, but rather to serve as an overview in order to provide an understanding 
of the work detailed in the following chapters. For a more comprehensive overview 
of the field from a bioinformatics point of view see for example (Eidhammer, et al., 
2007) or (Liebler, 2002), on which most of the following is based. Additional details 
regarding the underlying biochemistry that proteomics builds upon can be found in 
(Nelson and Cox, 2000) and (Creighton, 1996). 
 
1.1 What is Proteomics? 
Proteomics is one of the many ‘omics’ terms coined in the last couple of decades, 
with genomics (the study of the genomes of organisms) being among the most well 
known. The term proteomics is used as an analogy to genomics, based on a 
combination of the two terms ‘protein’ and ‘genome’, resulting in ‘proteome’. 
Proteomics can be defined as “the study of the proteome, the protein complement of 
the genome, including the study of protein structure and function” (Liebler, 2002). 
The field of proteomics can roughly be divided into three central and related tasks:  
• Protein Identification: Identify which protein(s) one is considering, i.e., which 
proteins are in a sample. 
• Protein Characterization: All sorts of analyses (mainly experimental) for finding 
the properties of a protein. Relevant properties can be purity, charge, mass, 
isoelectric point, reactivity, post-translational modifications, structure, 
stability, amino acid composition, amino acid sequence and potential binding 
to other proteins.
1
 
• Protein Quantification: Detecting the abundance of proteins in a sample, or 
across different samples which in many cases are obtained at different time 
points. 
The most common technique to achieve these tasks is using mass spectrometry (MS), 
both as single MS (or simply MS) and as Tandem MS, most often referred to as 
                                                           
1
 Note that some of these properties can be determined by the identification of the protein, like 
amino acid composition and sequence. 
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MS/MS. But before delving into the details of mass spectrometry itself and the 
analysis of the results of such experiments, a closer look at the properties of the input 
provided to the MS instruments is necessary. 
 
1.2 Proteins and the Proteome 
“Proteins are the most abundant biological macromolecules, occurring in all cells and 
all parts of the cell” (Nelson and Cox, 2000). Creighton (Creighton, 1996) describes 
the important role of the proteins as: “Virtually every property that characterizes a 
living organism is affected by proteins. Nucleic acids (…) encode genetic information – 
mostly specifications for the structure of proteins – and the expression of that 
information depends almost entirely of proteins (…).” In other words, the proteins 
expressed in a given cell at a given time are essential for the properties of that cell. 
Zooming out, the same can also be stated for the organism as a whole. 
Which proteins are expressed at a certain time, and the abundance of each individual 
protein, are dependent on many factors, e.g., the state of the cell and organism, 
resulting in an ever changing set of proteins present. This means that a cell’s 
proteome is constantly changing. On the other hand, the proteome’s genomic 
counterpart, the genome, is generally considered stable for a given organism 
(disregarding mutations etc). This calls for a closer look at the relationship between 
the genome and the proteome, contained in what is referred to as the central dogma 
in molecular biology, see Figure 1. 
 
 
 
 
 
 
 
 
DNA mRNA Protein 
Replication 
Transcription Translation 
Figure 1: Schematic illustration of the central dogma of molecular biology, 
where the gene (from DNA) is transcribed into mRNA, which is then 
translated into a protein. Also shown is the process called replication, 
where DNA is replicated in order to make a copy of itself. 
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Note that even though mRNA can be translated to a protein, there is no guarantee 
that all copies of a given mRNA molecule are translated; in fact, rather the opposite is 
true in many cases (Collins, 2001). An mRNA molecule may also be translated many 
times, yielding one protein molecule per round of translation. This means that there 
is usually not a 1:1 ratio between the amount of mRNA produced and the abundance 
of the corresponding protein. In addition, mRNAs and proteins are also exposed to 
degradation which changes the abundance of the protein. Together this means that 
the ability to measure the amount of mRNA in a cell, e.g., using microarrays (Causton, 
et al., 2003), does not directly give you the abundance of the encoded proteins at the 
given time in the studied cell. To achieve this one needs to identify and quantify the 
proteins directly, and this is where approaches from the field of proteomics can be 
applied. 
 
  Name Abbr. 1 Abbr. 2 Mono Mass Avg Mass pI Hydropathy 
1 Alanine Ala A 71.03711 71.0788 6.01 1.8 
2 Cysteine Cys C 103.0092 103.1448 5.07 2.5 
3 Aspartate Asp D 115.0269 115.0886 2.77 -3.5 
4 Glutamate Glu E 129.0426 129.1155 3.22 -3.5 
5 Phenylalanine Phe F 147.0684 147.1766 5.48 2.8 
6 Glycine Gly G 57.02146 57.052 5.97 -0.4 
7 Histidine His H 137.0589 137.1412 7.59 -3.2 
8 Isoleucine Ile I 113.0841 113.1595 6.02 4.5 
9 Lysine Lys K 128.095 128.1742 9.74 -3.9 
10 Leucine Leu L 113.0841 113.1595 5.98 3.8 
11 Methionine Met M 131.0405 131.1986 5.74 1.9 
12 Asparagine Asn N 114.0429 114.1039 5.41 -3.5 
13 Proline Pro P 97.05276 97.1167 6.48 1.6 
14 Glutamine Gln Q 128.0586 128.1308 5.65 -3.5 
15 Arginine Arg R 156.1011 156.1876 10.76 -4.5 
16 Serine Ser S 87.03203 87.0782 5.68 -0.8 
17 Threonine Thr T 101.0477 101.1051 5.87 -0.7 
18 Valine Val V 99.06841 99.1326 5.97 4.2 
19 Tryptophan Trp W 186.0793 186.2133 5.89 -0.9 
20 Tyrosine Tyr Y 163.0633 163.176 5.66 -1.3 
 
Table 1: Listing of the 20 standard amino acids, including some of the important amino 
acid properties. The masses are taken from http://i-mass.com/guide/aamass.html and 
the other values are from (Nelson and Cox, 2000). Note that the masses are for the 
residues, while the pI is for the “free” amino acid. 
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The building blocks of proteins are the amino acids, of which there are 20 standard 
members, see Table 1. Each of the amino acids can be decoded from the DNA/mRNA 
molecules using the so-called genetic code. The genetic code is a set of rules by which 
information encoded in genetic material, i.e., DNA and mRNA sequences, is 
translated into amino acid sequences, i.e., proteins. It defines a mapping between tri-
nucleotide sequences, called codons, and the amino acids, see Table 2. Four different 
nucleotides are used in RNA: adenine, guanine, uracil and cytosine, most often 
denoted as A, G, U and C. In DNA, thymine, denoted as T, is used instead of uracil. 
Proteins can be studied at various levels of detail, from the amino acid sequence just 
described to its three-dimensional structure. Four levels are commonly used:  
 
 
  
2nd base 
U C A G 
  
U 
UUU Phenylalanine UCU Serine UAU Tyrosine UGU Cysteine 
  UUC Phenylalanine UCC Serine UAC Tyrosine UGC Cysteine 
  UUA Leucine UCA Serine UAA Stop! UGA Stop! 
  UUG Leucine UCG Serine UAG Stop! UGG Tryptophan 
  
C 
CUU Leucine CCU Proline CAU Histidine CGU Arginine 
  CUC Leucine CCC Proline CAC Histidine CGC Arginine 
  CUA Leucine CCA Proline CAA Glutamine CGA Arginine 
1st CUG Leucine CCG Proline CAG Glutamine CGG Arginine 
base 
A 
AUU Isoleucine ACU Threonine AAU Asparagine AGU Serine 
  AUC Isoleucine ACC Threonine AAC Asparagine AGC Serine 
  AUA Isoleucine ACA Threonine AAA Lysine AGA Arginine 
  AUG Methionine* ACG Threonine AAG Lysine AGG Arginine 
  
G 
GUU Valine GCU Alanine GAU Aspartic acid GGU Glycine 
  GUC Valine GCC Alanine GAC Aspartic acid GGC Glycine 
  GUA Valine GCA Alanine GAA Glutamic acid GGA Glycine 
  GUG Valine GCG Alanine GAG Glutamic acid GGG Glycine 
 
Table 2: An overview of the standard genetic code. Color coding: yellow: non-polar; green: polar; 
blue: basic; red: acidic; grey: stop codon. *Note that AUG codes for both Methionine and serves as 
an initiation site, i.e., the first AUG in an mRNA's coding region is where the translation begins. 
(Figure reworked from http://en.wikipedia.org.) 
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• Primary Structure: The amino acid sequence. 
• Secondary Structure: Regularly repeating local structures, e.g., alpha helices, 
beta sheets and turns. 
• Tertiary Structure: The overall shape of a single protein molecule; the spatial 
relationship of the secondary structure elements to one another. 
• Quaternary Structure: The structure formed by several protein molecules, 
referred to as protein subunits, functioning as a single protein complex. 
This thesis will almost exclusively focus on the primary structure, from now on simply 
referred to as the amino acid sequence. For a more in depth discussion about the 
other levels see (Creighton, 1996). 
 
1.2.1 Protein Sequence Databases 
In almost all cases a protein’s primary structure can uniquely identify a particular 
protein. As a result of this several protein sequence databases have been created in 
which the amino acid sequences of known proteins are accumulated. Among the 
most prominent are UniProtKB/Swiss-Prot (manually annotated and reviewed) and 
UniProtKB/TrEMBL (automatically annotated and not reviewed), both located at 
http://www.uniprot.org and maintained by the UniProt Consortium (UniProt 
Consortium, 2010). In addition to these large general databases, a multitude of other 
options also exist, all the way down to specialized repositories aimed at single 
organisms or species, e.g., the Influenza Sequence Database (http://flu.lanl.gov). 
By searching such databases, either with the complete protein sequence or with parts 
of the sequence, it is in many cases possible to identify the protein in question.
2
 This 
approach will be covered in more detail in Chapter 1.4.2, where identification by 
(partial) protein sequence information will be explained.  
It is worth noting that while the protein’s primary sequence is most often unique, the 
same is not necessarily true for a protein’s accession number across different 
databases. As a response, both universal accession numbers based on the sequence 
(Babnigg and Giometti, 2006) and ways of mapping between accession numbers from 
different databases (Côté, et al., 2007) have been developed. 
 
                                                           
2
 Note that it is also possible to identify proteins by searching in databases of DNA sequences, but 
this adds additional challenges, e.g., regarding tri-nucleotide reading frames. 
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1.3 Mass Spectrometry 
Mass spectrometry, from here onwards simply referred to as MS, has been around 
for a long time. However, its use as a tool for analyzing proteomics data, or more 
specifically proteins, is a more recent development, and this approach, often referred 
to as protein mass spectrometry, will be the focus of the following sections. MS can 
generally be defined as an analytical technique for measuring the inertial mass of 
(charged) molecules. In protein MS the main usage is the identification of the 
peptide(s) and protein(s) in a sample, which have first gone through a sample 
preparation stage. The main steps included in the sample preparation stage will now 
be sketched, followed by an overview of the properties of the most common MS 
instruments used in protein MS. 
 
1.3.1 Protein Sample Preparation 
The sample preparation may consist of several steps. For this brief explanation two 
steps will be highlighted: (i) protein separation; and (ii) protein digestion. However, it 
is important to note that the sample preparation includes additional steps that may 
influence the result of the analysis, e.g., how and how long the protein(s) are stored 
before being analyzed (Yi, et al., 2007). Generally it is recommended to keep all 
properties stable from experiment to experiment, but given that the optimal 
conditions can vary between experiments this may also have to be considered in the 
downstream analysis. 
 
1.3.1.1  Protein Separation 
In most cases it is not possible to analyze the complete proteome in a single MS 
experiment. This would generally result in a very complex sample that most likely 
would be hard to evaluate. Several procedures for separating the proteins in a 
sample have therefore been developed. Two-dimensional gel electrophoresis 
(O'Farrell, 1975) used to be the primary tool for separating proteins prior to MS 
analysis (Wittmann-Liebold, et al., 2006). However, in the last couple of years gel-free 
approaches have been developed and adopted by a growing number of labs (Gevaert, 
et al., 2005; Lambert, et al., 2005; Swanson and Washburn, 2005). 
The common 2D gel electrophoresis first separates proteins by isoelectric focusing, 
followed by a 1D gel electrophoresis. Thus, the proteins are first separated along one 
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axis according to their isoelectric point, followed by an orthogonal separation 
according to their apparent molecular weight. This results in a 2D separation, with 
the proteins separated across the gel according to the two chosen properties. 2D gel 
electrophoresis has proven efficient at separating complex protein samples into 
discrete protein spots.
3
 In addition to good separation the technique has the 
advantage that the spots can be visualized, either for the human eye or for further 
computer analysis. After 2D gel separation each spot can be excised and analyzed 
using MS, hopefully resulting in the identification of the protein(s) contained in each 
spot. 
For the gel-free approaches the most common technique uses liquid chromatography 
(LC) to separate the proteins or peptides (see next section) prior to MS analysis. LC 
works by having the molecules present in a solution, which is then forced through a 
narrow column packed with material interacting with the molecules. The more 
interaction, the longer it takes the molecules to travel through the column, thus 
achieving separation of the molecules. Two main types of LC setups used in 
proteomics are: (i) reverse phase high pressure liquid chromatography (RP-HPLC), 
using hydrophobicity to separate the molecules; and (ii) ion exchange 
chromatography (either strong cation exchange (SCX) or strong anion exchange 
(SAX)), using charge to separate the molecules. 
An alternative approach is the use of affinity chromatography, used for selective 
enrichment, e.g., immobilized metal ion affinity chromatography (IMAC) for 
phosphopeptides (Thingholm, et al., 2009), and depletion, e.g., the plasma proteome 
(Pernemalm, et al., 2009). 
 
1.3.1.2  Protein Digestion 
While analyzing intact proteins is possible, in most cases proteins are cleaved into 
smaller pieces called peptides before analysis, in a process referred to as protein 
digestion.
4
 Cleaving a protein into peptides can be performed chemically, but is most 
often achieved by adding a protease to the sample mixture. The protease will in most 
                                                           
3
 Note that a spot may include more than one protein, and that a given protein may be spread over 
several spots, e.g., due to post-translational modifications. 
4
 The main reason for digestion proteins into peptides is that peptides are more suitable for MS 
analysis, and the redundancy introduced by cleaving multiple copies of the same protein also 
increases the reliability of the identification. Finally, the demands on the MS instruments regarding 
accuracy and resolution also increases dramatically when doing the analysis on complete proteins. 
For further details about so-called top-down proteomics, see (Eidhammer, et al., 2007). 
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cases be a high-specificity protease, meaning that it cleaves the protein sequence at 
specific sites called cleavage sites. Trypsin is by far the most commonly used 
protease, but other alternatives are also employed, e.g., chymotrypsin, GluC, LysC 
and AspN. In addition, proteases with non-specific cleavage sites, meaning that they 
cleave the protein more or less randomly, are used in very specific applications. 
However, such proteases are not applied in the work presented in this thesis and will 
therefore not be covered in more detail. 
Peptides obtained for MS analysis should exhibit certain characteristics in order to 
get optimal results. The length of the peptides should not be too short or too long, as 
this will interfere with their separation on an LC system, and will make them too light 
or too heavy to analyze accurately on a mass spectrometer. The peptides should also 
(for reasons that will be explained later) contain at least one amino acid residue that 
has the ability to accommodate a positive charge, i.e., a proton. For these reasons 
many potential proteases become less attractive, while trypsin often is the best 
choice. However, there are also situations where the properties of the proteins are 
better suited for a different protease. This aspect will be further explored in Chapter 
2.3 and in Paper III. 
The cleavage site(s) of a protease can be described as a regular expression. For 
example trypsin cleaves the protein sequence after the amino acids arginine (R) and 
lysine (K), unless followed by a proline (P), resulting in the regular expression [RK][^P] 
(using the Java/Perl regular expression annotation). Using these types of expressions 
makes it possible to in silico cleave a particular protein sequence with a given 
protease. This procedure is relied upon when matching experimentally cleaved 
proteins to protein sequences in a database (see Chapter 1.4.2 for more details). 
 
1.3.2 Mass Spectrometry Instruments 
Mass spectrometry instruments, or mass spectrometers, can be split into three 
distinct components: (i) the ion source; (ii) the mass (to charge) analyzer; and (iii) the 
detector. Generally the peptides start the journey in the ion source, where they are 
transferred to the gas phase as charged ions. These are then transported to the mass 
analyzer where the ions are separated according to their mass to charge (m/z) ratio. 
Finally, the detector records the flow of charged molecules, resulting in a mass 
spectrum, with the m/z value of each molecule on the horizontal axis and the 
intensity for each m/z on the vertical axis, see Figure 2. 
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In addition, most mass spectrometers used in protein MS today are capable of 
breaking the peptide bonds in the peptides, thus creating (peptide) fragment ions 
resulting in fragmentation spectra. To distinguish between the two types of spectra, 
the first is labeled MS spectrum, and the second MS/MS spectrum, as most 
instruments do this in a two-step procedure. Indeed, an MS/MS spectrum is created 
by selecting an m/z interval from the first MS spectrum prior to fragmentation, and a 
second MS analysis is then applied for the fragments produced. The analysis of both 
types of spectra will be discussed in more detail in Chapter 1.4. 
Several types of MS instruments exist, each with their own strengths and 
weaknesses, and the optimal instrument may vary according to the specific problem 
studied or the question asked. However, some properties can be compared across 
experiments, mainly accuracy, precision and resolution. 
 
1.3.2.1  Accuracy, Precision and Resolution 
The three concepts of accuracy, precision and resolution are all closely related. 
Accuracy is here defined as the distance from the measured value to its correct mass 
value, and is most often given as a mass deviation, either as an absolute value, e.g., 
0.5 Da, or as a relative value, e.g., 100 ppm. Relative values are used because the 
accuracy is usually found to be a function of the measured m/z. Precision on the 
other hand is the instrument’s ability to reproduce the results if the experiment is 
repeated multiple times. Note that accuracy and precision may be improved (to the 
limits of the capabilities of the instrument) by proper calibration of the instrument. 
Finally, resolution is the instrument’s ability to separate molecules with similar mass 
values. Resolution is most often defined using the formula: resolution = (measured 
Intensity 
m/z 
Figure 2: Schematic illustration of a mass spectrum. 
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mass value) / (width of peak at a given fraction of the maximum height). The Full 
Width of the peak at Half its Maximum height (FWHM) is commonly used, where the 
width is measured at 50% of the maximum height.  
Note that while the three properties are typically related there is no guarantee that 
an instrument with good accuracy has good precision and/or good resolution etc. In 
fact, different types of instruments differ quite significantly in these properties. 
 
1.3.2.2  Ionization Methods 
The transfer of the analyte molecules from a solid or liquid state to charged 
molecules in the gas phase is usually achieved using one of two distinct ionization 
methods: matrix assisted laser desorption and ionization (MALDI) or electro-spray 
ionization (ESI). An important distinction between these is that in ESI the molecules 
are dispersed as a fine aerosol, i.e., an electro-spray, into the MS instrument, thus 
using up the analyte over time, while in the MALDI the molecules are crystallized in a 
solid state on a stationary target making it possible to perform several experiments 
on the same sample spread over time. 
 
1.3.2.3  Mass Analyzers 
The mass analyzer separates charged molecules based on their m/z values. Several 
types of analyzer exist, but by far the most commonly used analyzers in protein MS 
are: quadrupole, quadrupole ion trap, time of flight, Fourier transform ion cyclotron 
resonance and orbitrap. 
The quadrupole instruments consist of four circular (or ideally hyperbolic) metal rods, 
set perfectly parallel to each other. Quadrupoles filter the ions based on the stability 
of their trajectories in the oscillating electric fields applied to the rods. At a given 
voltage frequency, only peptides within certain m/z thresholds will be able to pass 
through the four rods. By varying the voltage frequency the ions can thus be 
separated based on their m/z values. 
A variation of the quadrupole is the quadrupole ion trap. Unlike a regular quadrupole, 
an ion trap has the ability to contain ions within given m/z thresholds, hence the 
name ion trap. The trapped ions can then by targeted for further analysis, mainly for 
fragmentation resulting in MS/MS spectra. Actual separation of the ions by m/z 
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occurs when the oscillating electrical fields in the trap are tuned to eject a particular 
m/z range out of the trap, towards the detector. 
Time of flight instruments have a different way of separating the ions. First the ions 
are accelerated by an electric field of known strength, resulting in equal kinetic 
energy for all the ions of the same charge. The velocity of the ions then depends on 
the mass to charge ratio of the ions, and the time required for the ion to reach a 
detector at a known distance is measured. The larger inertial mass of heavier ions will 
restrict them to lower speeds compared to lighter ions of the same charge. This 
difference in velocity results in different flight times, and the recorded times 
(together with the known experimental parameters) can be used to calculate the m/z 
value of each ion. 
Fourier transform ion cyclotron resonance instruments determine the m/z values 
based on the cyclotron frequency of the ions in a very powerful, fixed 
electromagnetic field, and do not separate the ions in time or space. The moving 
charge is creating a moving electromagnetic field superimposed on the fixed 
electromagnetic field, which can be measured with extreme exactness. The combined 
cyclotron paths of the ions result in a highly complex wave, which can be translated 
to mass spectra by applying a Fourier transformation on this compound signal. 
Orbitraps are also able to trap ions, but use a different strategy compared to the 
quadrupole ion trap. Here the ions are trapped using an electrostatic field. The ions 
orbit a central electrode, with the centrifugal forces caused by their velocity 
counteracting the electrostatic attraction towards this central electrode, making the 
ions move in complex patterns. Fourier transformations of the oscillating frequencies 
are then used to calculate the m/z values. 
 
1.3.2.4  Detectors 
The final component of the MS instrument is the detector, which is responsible for 
recording a passing or impacting ion, and forwarding this information in digital form 
to a computer for further processing. Most impact-based detectors rely on a form of 
electron cascade over multiple Faraday cups for ion impacts to translate into 
measurable electronic signals. These signals are in the end transformed into the MS 
(or MS/MS) spectrum that can be further investigated in order to identify the 
peptides and proteins in the analyzed sample, which is the main topic of the next 
chapter. 
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1.3.3 Peptide Fragmentation 
There are several techniques for inducing peptide fragmentation, but the most 
common is Collision-Induced Dissociation (CID) (also referred to as Collisionally 
Activated Dissociation or CAD). In this approach potential energy is built up in the 
peptides through repeated collisions with an inert gas, e.g., argon. When an energy 
threshold is reached, bonds are broken and fragmentation into fragment ions and 
neutral losses occurs.
5
 Other techniques also exist, e.g., Electron Transfer Dissociation 
(ETD) (Mikesh, et al., 2006) and Electron Capture Dissociation (ECD) (Zubarev, et al., 
2000), but the overall concept of fragmentation remains the same. However, the 
types of fragment ions formed can vary depending on the technique used, see e.g., 
(Boersema, et al., 2009). 
The fragmentation process is not yet fully understood. Although various efforts have 
increased the knowledge about the process, e.g., (Klammer, et al., 2008; Wysocki, et 
al., 2000; Zhang, 2004; Zhang, 2005), a lot still remains to be discovered. There are 
basically two ways in which this knowledge can be obtained: either by a bottom-up 
chemical approach aimed at understanding the chemical processes leading to the 
fragmentation, or by a top-down statistical approach where existing fragmentation 
data is analyzed in order to find patterns. The latter approach will be further detailed 
in Chapter 2.4 and in Paper IV and V. 
One of the most well-known models arrived at (mainly) by using the chemical 
approach is the so-called Mobile Proton Model. This model states that as the 
dissociation energy increases, the added proton(s) will move to a protonation site, if 
they are not sequestered by a basic amino acid side chain (arginine, lysine or 
histidine). The proteins typically migrate to an atom at the amide bond, resulting in 
the formation of b and/or y fragment ions (see below). In addition it assumes that 
when the proton(s) are located at the basic amino acids one gets low proton 
mobilization. Further details can be found in (Paizs and Suhai, 2005). 
Fragmenting peptides is not a completely random process where the peptides end up 
in arbitrary pieces. In most cases the peptides are mainly cleaved along the peptide 
backbone by cleaving the peptide bonds, which can happen in three ways. Depending 
on which side of the breakage the proton(s) are located six different fragment ion 
types can be formed from the breaking of a given peptide bond, see Figure 3. If the 
charge is retained on the N terminal side a, b or c ions are created, and if the charge 
                                                           
5
  In this context the peptides are more generally referred to as the precursor ions and the fragment 
ions as product ions. 
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is retained in the C terminal side x, y or z ions are created (Roepstorff and Fohlman, 
1984). 
Other types of fragmentation are also possible, e.g., internal cleavage ions (the 
backbone is cleaved more than once), immonium ions (a single ionized residue, 
formed by a combination of a type and y type cleavage) and satellite ions (ion types 
due to side chain cleavages). In addition, the fragments can have so-called neutral 
losses resulting in a mass shift of the fragment ion. Most neutral losses occur from 
the side chain of the amino acid residues, and consist of the loss of H2O or NH3, or the 
loss of modifications like phosphate. 
 
1.4 Analyzing Mass Spectrometry Data 
The output from mass spectrometers, i.e., the spectra, has to be analyzed by 
bioinformatics tools in order to identify, characterize and quantify the peptides and 
proteins in the samples. Before going into these details, an overview of the initial 
post-processing of the mass spectra will be given. 
 
1.4.1 Raw Spectra vs. Peak Lists 
Unprocessed spectra produced by MS instruments are often referred to as raw 
spectra, or simply raw data, and usually go through an initial post-processing step, 
which  
 
 
x3    y3   z3    x2   y2   z2    x1   y1   z1   
a1   b1   c1    a2   b2   c2    a3   b3   c3   
H H H H H H H 
R1 R4 
H2N – C – C – N – C – C – N – C – C – N – C – COOH  
–
 
–
 –
 
–
 
–
 
–
 
–
 
–
 –
 
–
 
R2 R3 O O O 
–
 
Figure 3: Illustration of the standard fragment ions which can be formed when 
fragmenting a peptide of length four. R1 to R4 represent the side chains of the 
amino acid residues. 
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which mainly converts the continuous mass spectrometric measurements from the 
raw spectra into lists of ion peaks. Post-processing detects peaks in a raw spectrum 
and converts them into a peak list which only contains the properties of each peak, 
i.e., the m/z value, the intensity, etc. This conversion from a continuous spectrum to 
a discrete spectrum greatly simplifies the later analysis and also reduces the space 
required for storing the spectra (Martens, et al., 2005). 
As a part of the peak detection, the post-processing step may include one or more of 
the following: noise reduction, baseline correction, smoothing, intensity 
normalization and calibration. The process of monoisotoping or deisotoping and the 
removal of non-peptide masses may also be employed at this stage. For additional 
details see (Eidhammer, et al., 2007).  
 
1.4.2 Protein and Peptide Identification 
The identification of proteins using MS can be categorized based on the type of 
spectra used, i.e., (single) MS or MS/MS. When MS data from digested proteins are 
used the process is referred to as Peptide Mass Fingerprinting (PMF) (Cottrell, 1994). 
Figure 4 shows an overview of the process. Identification relying on MS/MS spectra of 
individual peptides is a similar process, see Figure 5, but there are important 
differences between the two which will now be highlighted. 
 
1.4.2.1  Peptide Mass Fingerprinting 
In peptide mass fingerprinting (PMF) the unknown protein is first cleaved into 
peptides, which are then inserted into an MS instrument measuring the m/z and 
intensity values of each peptide, resulting in an MS spectrum. Ideally, each peak in 
the spectrum corresponds to one peptide from the protein. This spectrum is then 
compared to in silico digested proteins from a database, and statistical methods are 
used to detect the best match. PMF is a fairly simple procedure, but as a result of this 
it has several drawbacks. For example it can only be used to identify proteins that are 
already in the database. Additionally, identifying more than one or two proteins at 
the same time becomes difficult, and the procedure is thus normally limited to highly 
purified proteins. Furthermore, it may be difficult to pinpoint post-translational 
modifications and their exact position(s) (see Chapter 1.4.3.1). This limitation will be 
further discussed in Chapter 2.1 and 2.3 and in Paper I and III. 
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… -A-C-M-L-L-Y-R-F-F-S-R-N-T-K- …       Protein Sequence 
…      A-C-M-L-L-Y-R      F-F-S-R      N-T-K      …       Peptides 
Digestion 
MS Instrument 
Intensity 
m/z 
MS Spectrum 
 m/z  lower     upper        height          intensity           area 
1 749.41178 749.41     749.41         697.0              6.96               697.39 
2           927.44482 927.44     927.44       1119.0            11.16            1118.76 
3   … 
Post-Processing 
Database Search 
Protein Identification 
Peak List 
MS 
Figure 4: Simplified view of the process of protein identification via MS spectra. Ideally 
one peak in the peak list refers to one peak in the spectrum which again corresponds 
to one peptide. The additional columns shown in the peak list refer to how the discrete 
peak list was created based on the original continuous spectrum. 
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A-C-M-L-L-Y-R        Peptide Sequence 
...      A-C     A-C-M      L-L-Y-R      YR      ...       Fragment Ions 
Fragmentation 
MS Instrument 
Intensity 
m/z 
MS/MS Spectrum 
 m/z  lower     upper         height          intensity         area 
1 342.41378 349.40     449.43          498.0          16.87     428.21 
2 422.41482 417.46     447.42        1316.0          27.32          1478.41 
3   … 
Post-Processing 
Database Search / De-novo Sequencing 
Peptide Identification 
Peak List 
MS/MS 
Figure 5: Simplified view of the process of peptide and protein identification via 
MS/MS spectra. Ideally one peak in the peak list refers to one peak in the spectrum 
which again corresponds to one fragment ion. The additional columns shown in the 
peak list refer to how the discrete peak list was created based on the original 
continuous spectrum. 
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1.4.2.2  Identification via Peptide Fragmentation 
Identification of proteins via the step of peptide fragmentation resolves some of the 
shortcomings of PMF. In this approach the selected peptides are fragmented into 
fragment ions which then make up the MS/MS spectra, see Figure 5. In contrast to 
the spectra used in PMF, each peak in the spectrum now ideally corresponds to one 
fragment ion. The spectra can be identified similarly to the PMF spectra, by 
comparing them to in silico digested peptides in a database, or by a method referred 
to as de novo sequencing.  
Identification of MS/MS spectra via database search is the most commonly used 
technique in protein MS today, and various algorithms have been developed for this 
purpose, e.g.,  
• SEQUEST (Eng, et al., 1994; Yates, et al., 1995) 
[http://fields.scripps.edu/sequest] 
• Mascot (Perkins, et al., 1999) [http://www.matrixscience.com] 
• X!Tandem (Fenyo and Beavis, 2003) [http://www.thegpm.org/tandem] 
• OMSSA (Geer, et al., 2004) [http://pubchem.ncbi.nlm.nih.gov/omssa] 
• VEMS (Matthiesen, 2007) [http://personal.cicbiogune.es/rmatthiesen] 
Despite the different algorithms used, three main principles can be recognized. Given 
an MS/MS spectrum S, and a mass error threshold ∂: 
1. Find all peptides in the database having a mass similar to the precursor 
peptide of S, within the mass error threshold ∂. 
2. Compare the theoretical fragment spectrum of each potential peptide to S. 
3. Calculate a score for the match between the theoretical and the experimental 
spectrum. 
Depending on the algorithm and scoring scheme used, the possible matches are then 
usually ranked and a list of the best matches is presented. 
If a peptide cannot be identified via a database search, for example if the peptide 
contains novel or unknown modifications, it is in many cases possible to extract 
(partial) sequence information via the method of de novo sequencing by utilizing the 
information available in the spectrum, mainly the existing peaks and the distances 
between the peaks. De novo sequencing consists of a variety of similar methods, 
most of which are based on graph theory, and can either be performed manually or 
by using automated software tools, e.g., Peaks (Ma, et al., 2003) and PepNovo (Frank 
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and Pevzner, 2005). A more in depth view of the details of de novo sequencing can be 
found in (Eidhammer, et al., 2007). 
 
1.4.3 Protein Characterization 
Protein characterization is usually performed after identification, in an attempt to 
obtain more details about a given protein, e.g., detecting the exact protein sequence 
(which could be altered due to mutations) or locating post-translational 
modifications. Such knowledge can prove essential when trying to understand a 
protein’s role in the bigger context of a cell or an organism as a whole. However, 
given that these types of analyses for the most part focus on specific types or groups 
of proteins, and that the investigations most often are of an experimental nature, this 
component of proteomics, with the exception of the detection of post-translational 
modifications described below, will not be further detailed in this thesis. 
 
1.4.3.1  Post-Translational Modifications 
A post-translational modification is defined as a chemical modification of a protein 
after its translation, and can be either naturally occurring or chemically induced 
(either intentionally or unintentionally) during sample handling.
6
 The existence of 
post-translational modifications is a complicating factor in all types of proteomics 
analysis. Generally a modification changes the mass of the modified amino acid and 
thus changes the mass of all peptides and fragment ions where the given residue is 
included. 
There are in principle two ways of dealing with post-translational modifications, 
either by defining a set of modifications to be considered before the analysis begins, 
or by treating the modifications as unknown. Defining a (presumably short) list in 
advance results in a larger search space and in longer search times, but does not 
complicate the identification process significantly.
7
 This is therefore the approach 
supported by most search algorithms. However, in many cases it is very difficult to 
predict all the modifications in a protein, e.g., when trying to detect novel 
modifications. In these situations more advanced techniques are required, but most 
                                                           
6
 In addition to post-translational modifications, there are co-translational modifications, i.e., 
modifications occurring during the translation from mRNA to protein, but at the level of mass 
spectrometry these two types can be handled identically. 
7
   There can also be an increased chance of false positive identifications. 
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of these will significantly complicate the search and drastically increase the running 
time of the algorithm. One method that can be used to detect unknown 
modifications in PMF data will be discussed in Chapter 2.3 and in Paper III. 
 
1.4.4 Protein Quantification 
A task that is closely related to protein identification is the task of protein 
quantification, i.e., measuring the (absolute or relative) amount of protein in a 
sample. The ultimate goal of protein quantification is to be able to quantify the 
abundance of individual proteins in a sample, in many cases also across a set of 
samples taken at different time points. Comparing spectra obtained from different 
samples at different times results in a whole new set of issues regarding sample 
equality etc. These issues will however not be discussed further here. For the sake of 
simplicity it will also be assumed that only two samples are to be compared, but most 
approaches can be extended to more than two samples. 
Protein quantification can be divided into two groups: label-based and label-free 
approaches. In label-based quantification either proteins or peptides from one of the 
samples are labeled, or both samples are labeled using different labels. Since the 
labels are constructed to show up as mass differences in the mass spectrometer, it 
becomes possible to distinguish proteins from the two samples by their mass, and 
extract the abundance of the detected proteins for each sample based on the 
measured ion intensity. Examples of label based methods are: ICAT (Gygi, et al., 
1999), iTRAQ (Zieske, 2006) and SILAC (Ong, et al., 2002).  
As the name suggests the label-free quantification methods do not apply any labels 
to the samples, but rather rely on MS data from separate LC-MS runs. Different 
techniques for calculating the difference between the spectra are then used to arrive 
at the abundance of each protein, e.g., quantification using the number of peptide 
identifications (spectral counting), protein sequence coverage (e.g., emPAI (Ishihama, 
et al., 2005)), or quantification by ion current. More details can be found in (Wong, et 
al., 2008). 
An overview of the existing peptide and protein quantification methods, along with a 
discussion of issues they raise with a focus on data processing can be found in 
(Vaudel, et al., 2010). 
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1.5 Publicly Available Proteomics Data 
Publicly available data repositories are the standard for most research areas in the 
life sciences, of which the most common examples are: 
• Protein Sequences:  
o UniProtKB/Swiss-Prot and  
UniProtKB/TrEMBL (UniProt Consortium, 2010) [www.uniprot.org]  
• Protein Structures:  
o PDB (Berman, et al., 2007) [www.rcsb.org] 
• Amino Acid Modifications: 
o UniMod (Creasy and Cottrell, 2004) [www.unimod.org]  
o RESID (Garavelli, 2004) [www.ebi.ac.uk/RESID]  
• Peptide and Protein Identifications:  
o PRIDE (Martens, et al., 2005) [www.ebi.ac.uk/pride] 
o PeptideAtlas (Deutsch, et al., 2008) [www.peptideatlas.org] 
o Human ProteinPedia (Keshava Prasad, et al., 2009) 
[www.humanproteinpedia.org] 
o GPMDB (Beavis, 2006) [http://gpmdb.thegpm.org] 
• Functional Genomics / Microarray Data: 
o ArrayExpress (Brazma, et al., 2003) [www.ebi.ac.uk/microarray-as/ae] 
Note that this is not an exhaustive list; it merely provides examples of some of the 
most commonly used repositories. 
Making the data publicly available has many advantages, both at the individual data 
set level and perhaps most importantly at the more general repository level. 
Particular data sets can be tested and reanalyzed in order to verify any results 
published based on the data. The larger gathering of data also makes it possible to 
analyze all the data to look for specific patterns or properties (Klie, et al., 2008; 
Mueller, et al., 2008). However, the most useful feature will in many cases be the 
possibility of searching the data in order to identify an unknown sample and to 
further characterize a sample after identification, e.g., identify a protein by searching 
in a protein sequence database and then using information about the matching 
proteins to further characterize the protein in question. 
Most of the data repositories mentioned above are fairly successful and already 
contain large amounts of data. The peptide and protein identification repositories are 
however lagging a bit behind compared to other data types in the life sciences. One 
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obvious reason for this is that in most cases the peptide and protein identification 
repositories have been around for a shorter period of time. But the somewhat limited 
success (so far) can also be explained by three complicating factors: (i) relatively 
complex data sets; (ii) relatively large data sets; and (iii) an (until recently) lack of 
data standards. For all these reasons, peptide and protein identifications present 
additional challenges compared to other data types. However, all of these issues are 
now being addressed, and the situation is starting to improve markedly. The 
introduction of data standards (detailed in the next sections) is the key element in 
solving most of the issues, but implementing ways of handling large and complex 
data sets in an efficient and simple manner is an equally crucial aspect. 
 
1.5.1 Data Formats 
Proteomics data have been around for a while, and it is of no surprise that a large 
amount of different data formats have been developed over the years. Even when 
limiting the scope to peptide and protein identifications from MS data alone, a long 
list can be produced. Here is a short list of some of the currently used data formats 
for MS data (both as spectra only and as spectra and identifications): 
Mascot DAT files, Mascot generic files, X!Tandem XML files, Micromass PKL files, 
SEQUEST DTA files, SEQUEST OUT files, OMSSA OMX files, mzXML, mzData, 
mzML, PRIDE XML files, Proteios XML files, VEMS PKX files, Phenyx Pidres XML 
files, Applied Biosystems Data Explorer PKM files, Bruker XML files, Finnigan ACS 
files, PerSeptive PKS files, PDF files. 
It is not difficult to see that the lack of standard formats results in additional issues 
when the data is to be submitted to public repositories, or when data is to be 
transferred from one lab to another, or even inside the same lab if different 
instruments are used. To be able to use the data in any of these formats, the user has 
to be familiar with the format (in order to find the desired section of the file) and be 
able to extract the requested information. This puts a heavy burden on the user, 
which in many cases will result in potentially valuable information being disregarded 
due to inaccessibility. 
To resolve the above situation three features have to be implemented: (i) general 
data standards for MS data sets; (ii) simple tools for converting data to the standard 
formats; and (iii) simple tools for viewing and extracting data from the standard 
formats. Only when all of these are in place will it be possible to shift the focus from 
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the data format to the actual data, which will drastically increase the usability of the 
available information. 
 
1.5.2 Standards 
The idea of creating standards for proteomics data is not new, and in some cases 
several local standards have been proposed by individual labs (McDonald, et al., 
2004; Pedrioli, et al., 2004). However, it is not until recently that all of these efforts 
were gathered under the single umbrella of the HUPO-PSI (Human Proteome 
Organization – Proteomics Standards Initiative) organization, founded at the HUPO 
meeting in Washington in April 2002 (Kaiser, 2002). HUPO-PSI consists of various 
working groups focusing on different elements of the proteomics data standard: 
Protein Separation, Mass Spectrometry, Molecular Interactions, Protein 
Modifications and Proteomics Informatics. In addition, two inter-group projects are 
defined: Controlled Vocabularies and MIAPE (Minimum Information About a 
Proteomics Experiment) (Taylor, 2006). Data standards developed by the HUPO-PSI 
are subjected to a thorough review cycle which includes both invited experts and a 
period of general feedback that is open to all interested parties (Vizcaíno, et al., 
2007). For more details about HUPO-PSI see http://www.psidev.info. 
For the work presented in this thesis two emerging standards are particularly 
important: mzML and mzIdentML. mzML is a standard for mass spectrometry data, 
while mzIdentML is a standard aimed at capturing the different types of analyses in 
which MS data can be used, e.g., the identification of peptides and proteins. Both 
have been released in early versions, but revisions are expected in the near future. 
The standards are already starting to take hold in the community and the number of 
instruments and tools supporting these formats are increasing. 
In addition to HUPO-PSI, a European 6
th
 Framework Programme funding initiative 
called ProDaC (Proteomics Data Collection) was also started, with the objectives to: 
(i) support standards development carried out by HUPO-PSI; (ii) develop conversion 
tools and integrate standards into products; and (iii) create a standardized workflow 
to submit proteomics data to central repositories. The ProDaC grant ended in March 
2009 and a summary of its activities and results can be found in (Eisenacher, et al., 
2009). 
The adoption of the standards by the community will also be pushed forward by the 
scientific journals, of which a growing number are starting to demand (or at least 
Proteomics 23 
 
 
 
 
strongly request) the deposition of proteomics data, e.g., the raw mass spectra, in 
public repositories for relevant manuscripts, see for example (Editors, 2007; Editors, 
2008) for the positions of the Nature Publishing Group. The number of journals 
enforcing this policy is already increasing, with Molecular and Cellular Proteomics 
recently following suit, for instance. 
 
1.5.2.1  Controlled Vocabularies and Ontologies 
Being able to read a given MS data format does not necessarily mean that one 
understands its contents, due to the distinction between syntax and semantics. Since 
a large amount of proteomics data is being produced, by a variety of different labs 
and by people with different backgrounds and different languages, it is not surprising 
that the vocabularies used to describe a given process may vary. And while these 
sorts of misunderstandings can be solved quite easily within a given lab, this becomes 
a lot more complicated in a broader, community-wide context. To solve this problem 
the concepts of controlled vocabularies (CVs) and ontologies were developed.  
A CV is defined as a limited list of clearly defined terms, with optional relationships 
between the terms, while an ontology moves beyond a mere CV by attempting to 
extensively model a part of the real world (Martens, et al., 2008). Using CVs and 
ontologies makes it possible to annotate data sets in a consistent way across 
different labs, making it much simpler to understand an unknown data set. 
Annotating data using CV terms also has additional advantages, some of which will be 
covered in more detail in Chapter 2.5 and in Paper VI and VII. 
 
1.5.3 Converters and Viewers 
Additional tools for converting data into standard formats and for viewing or 
manipulating the resulting standardized data files are also necessary. Without such 
tools the adoption of the standards would be more difficult and occur much less 
rapidly in the community. An important aspect of the standardization is that it will 
also make it easier to submit data to public repositories, thus resulting in more 
publicly available data and an easier access to this data. However, for this to be 
possible simple tools for converting local data to the standard formats are essential. 
These aspects will be further covered in Chapter 2.5 and in Paper VI and VII. 
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2 Contributed Tools and Analyses 
This chapter provides an overview of the tools and analyses contributed by the work 
in this thesis. For each subject the context of the given tool and/or analysis is 
described, and an overview of how it contributes to the field of proteomics is 
provided. All tools and analyses are further detailed in separate papers in the Papers 
section found at the end of the thesis. 
 
2.1 Peptide Mass Fingerprinting Data Analysis 
While large-scale proteomics via MS/MS is currently the most commonly used 
methodology in proteomics, small-scale experiments concentrating on one or a few 
proteins remain important as well. Such focused analyses are of particular interest 
when the aim is to characterize post-translational modifications in a given protein. A 
number of tools existed for doing small-scale protein identification, but very few of 
these included an administrative unit for collecting and analyzing data from several 
experiments on the same protein.  
As a response to this we created a system called MassSorter, which is especially 
developed for analyzing and comparing the result of several experiments on known 
proteins (‘known’ meaning that the sequence is available and known prior to the 
experiments). MassSorter consists of a set of analytical tools integrated around an 
administrative unit that functions as a database of all performed experiments. The 
basis for the in-depth analysis performed by MassSorter is the comparison of the 
experimental and theoretical data, in many cases relying on multiple experiments for 
a given protein. By using the available analysis options the known protein can 
thereafter be analyzed for sequence coverage and different forms of modifications. In 
addition, unexpected cleavages can be suggested. 
Note that the input to MassSorter is MS and not MS/MS data, and that this to some 
extent influences the abilities of the tool. The reason for not supporting MS/MS data 
is that the tool was aimed at (smaller) labs where MS/MS instruments were not 
available. 
This work is further detailed in Paper I. 
8
 
MassSorter is available at: http://services.cbu.uib.no/software/massSorter 
                                                           
8
  In addition a book chapter about the tool has been written (see Chapter 4.1 for details). 
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2.2 Protease-Dependent Fractional Mass and Peptide 
Properties 
Mass spectrometric analyses of peptides using protein mass fingerprints mainly rely 
on cleavage of proteins with proteases that have a defined specificity, and the 
specificities of the proteases imply that there is not a random distribution of amino 
acids in the peptides. This distribution had to some degree been analyzed previously 
for trypsin (the most common protease), but to a much lesser extent for other 
proteases. We therefore investigated the relationships between peptide fractional 
mass, pI and hydrophobicity for the three proteases trypsin, chymotrypsin and gluC, 
showing that the distribution of the fractional masses and the average regression 
lines for the fractional masses were similar, but not identical.  
The analysis shows that the fractional mass and some other properties of the 
peptides are dependent on the protease used for generating the peptides. With the 
increasing accuracy of mass spectrometers it is possible to exploit the information 
embedded in the fractional mass of unknown peaks when analyzing peptide mass 
fingerprint spectra, and improving the confidence in the identifications. 
This work is further detailed in Paper II. 
 
2.3 Post-Translational Modifications and Amino Acid 
Substitutions 
There are two main approaches for protein characterization: (i) using a predefined 
set of possible modifications and substitutions or (ii) performing a blind search. The 
first option is straightforward, but cannot (at least not directly) detect modifications 
or substitutions outside the predefined set. A blind search does not have this 
limitation, and therefore has the potential of detecting both expected and 
unexpected modifications and substitutions. Even previously unknown modifications 
can in principle be detected. 
In this analysis we propose a method using blind search on protein mass 
fingerprinting data from two different proteases. Combining the peptide mass 
fingerprints from two proteases results in overlapping sequence coverage of the 
protein, thereby offering an alternative view of the protein and a novel way of 
indicating post-translational modifications and amino acid substitutions. 
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To show how the method can be used we also implemented a simple application 
called MassShiftFinder which is able to locate equal mass shifts for overlapping 
peptides from the two proteases used, and can indicate both post-translational 
modifications and amino acid substitutions. In most cases it also suggests a restricted 
area within the overlapping peptides where the mass shift can occur. 
This work is further detailed in Paper III. 
MassShiftFinder is available at: http://services.cbu.uib.no/software/massShiftFinder 
 
2.4 Analyzing MS/MS Fragmentation Data 
Ideally, evaluation of obtained peptide and protein identifications should be based on 
a detailed understanding of the various processes involved in acquiring the 
experimental data, yet for crucial steps such as fragmentation, comprehensive 
knowledge remains elusive. There are two main approaches by which such 
knowledge can be acquired, either by a chemical understanding of how the 
fragmentation occurs, or by a statistical analysis of available fragmentation data. 
Trying to utilize the large amount of protein identifications available in the ms_lims 
database (Helsens, et al., 2010) at Ghent University, Belgium, we implemented a tool 
called Fragmentation Analyzer, which makes it simple and intuitive to analyze data 
from MS/MS experiments in order to understand the nuances of the fragmentation 
process in light of experimental conditions.  
The primary means through which the tool accomplishes this goal is by searching for 
multiple identifications of similar or equal peptides that differ in one or more user-
selectable parameters, e.g., instrument type, precursor charge and post-translational 
modifications. The resulting information can then be used to analyze the variation in 
fragmentation patterns and intensities caused by using different instruments, or by 
post-translational modification of the peptides, amongst others. 
In addition to the implementation of Fragmentation Analyzer we also used it to 
analyze existing peptide identifications. However, due to time limitations this work 
could not be completed before the writing of this thesis. An overview of our 
preliminary results and indications of remaining work are detailed in a separate (as 
yet unpublished) paper. 
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This work is further detailed in Paper IV and V. 
9
 
Fragmentation Analyzer is available at: http://fragmentation-
analyzer.googlecode.com 
 
2.5 Making Proteomics Data Sharing Easy  
With the continuously growing amount of proteomics data being produced, it has 
become increasingly important to make these data publicly available so that they can 
be audited, reanalyzed and reused. In addition, more and more journals are starting 
to request (and even require) the deposition of MS data in publicly available 
repositories for submitted proteomics manuscripts. This in turn necessitates that the 
uploading of data to public repositories is as easy as possible, which is not always the 
case.  
Our work focused on data deposition into the PRIDE database, which is rapidly 
becoming one of the most recommended data repositories for proteomics data. 
Several tools for submitting data to PRIDE already existed, but all of these had severe 
limitations, either supporting too few data formats, or being aimed almost exclusively 
at small scale submissions. We therefore developed PRIDE Converter, which makes it 
straightforward to prepare and annotate many of the most common data formats for 
submission to PRIDE. Through eight simple steps the relevant data are selected, 
annotated and converted in a wizard-like graphical user interface. 
The annotation of the data using controlled vocabulary terms and ontologies makes it 
much easier to compare and analyze data from different sources. However, finding 
the correct controlled vocabulary terms can sometimes be a difficult task for the end 
user. As a response the Ontology Lookup Service (Côté, et al., 2006; Côté, et al., 2008) 
was created. For PRIDE Converter we created a user-friendly Java front end to the 
Ontology Lookup Service, called the OLS Dialog, which can be plugged into any 
application requiring the annotation of data using controlled vocabulary terms, 
making it possible to find and use controlled vocabulary terms without requiring any 
additional knowledge about web services or ontology formats. 
In addition most of the data format converters had to be created more or less from 
scratch. Because of the scarcity of tools to access these widely used formats, some of 
                                                           
9
  Fragmentation Analyzer has been updated and extended since Paper IV was accepted, and now 
supports seven analysis types (not four as mentioned in the paper). 
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these were later transformed into standalone libraries that can be used to extract 
and visualize details from the data formats. Some of these have been published in 
separate publications, e.g., OMSSA Parser and XTandem Parser (see Chapter 4.1 for 
details). 
This work is further detailed in Paper VI and VII. 
10
 
PRIDE Converter is available at: http://pride-converter.googlecode.com 
OLS Dialog is available at: http://ols-dialog.googlecode.com 
  
                                                           
10
  Several additional papers highlighting the context of the tools or describing components of the 
tools have also been published (see Chapter 4.1 for details). 
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3 Contributing Papers 
 
3.1 List of Included Papers 
Below is a list of the papers contributing to the thesis, all of which are included at the 
end of the thesis, including supplementary material. All are available in the journals in 
which they are published, except Paper V which represents yet unpublished results. 
 
Paper I: 
Barsnes H, Mikalsen SO and Eidhammer I:  
MassSorter: a tool for administrating and analyzing data from mass 
spectrometry experiments on proteins with known amino acid sequences  
BMC Bioinformatics 2006 Jan 26; 7:42. 
(DOI: 10.1186/1471-2105-7-42, PMID: 16438723) 
 
Paper II: 
Barsnes H, Eidhammer I, Cruciani V and Mikalsen SO:  
Protease-dependent fractional mass and peptide properties 
European Journal of Mass Spectrometry 2008; 14; 311-317.  
(DOI: 10.1255/ejms.934, PMID: 19023148) 
 
Paper III: 
Barsnes H, Mikalsen SO and Eidhammer I:  
Blind search for post-translational modifications and amino acid  
substitutions using peptide mass fingerprints from two proteases 
BMC Research Notes 2008 Dec 19; 1:130.  
(DOI: 10.1186/1756-0500-1-130, PMID: 19099572) 
 
Paper IV: 
Barsnes H, Eidhammer I and Martens L:  
Fragmentation Analyzer: An open-source tool to analyze MS/MS  
fragmentation data 
Proteomics 2010; 10(5): 1087-90. 
(DOI: 10.1002/pmic.200900681, PMID: 20049869) 
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Paper V: 
Barsnes H, Eidhammer I and Martens L:  
Analyzing MS/MS Fragmentation Data 
(unpublished preliminary results) 
 
Paper VI: 
Barsnes H, Vizcaino JA, Eidhammer I and Martens L:  
PRIDE Converter: Making proteomics data-sharing easy 
Nature Biotechnology 27, 598 - 599 (2009). 
(DOI:10.1038/nbt0709-598, PMID: 19587657) 
 
Paper VII: 
Barsnes H, Côté R, Eidhammer I and Martens L:  
OLS Dialog: An open-source front end to the Ontology Lookup Service 
BMC Bioinformatics 2010 Jan 17; 11:34. 
(DOI: 10.1186/1471-2105-11-34, PMID: 20078892) 
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4 Additional Work 
 
4.1 List of Additional Papers 
Following is a list of papers describing additional work performed during the period 
when the PhD was carried out, but which are not included in the Papers section at 
the end of the thesis. The list mainly consist of papers: (i) highlighting additional 
aspects of the tools described in the included papers; (ii) describing various contexts 
where the developed tools are employed; or (iii) describing various spin-off projects 
based on the developed tools. 
 
Eidhammer I, Barsnes H and Mikalsen SO:  
MassSorter: Peptide Mass Fingerprinting Data Analysis 
Methods Mol Biol. 2008; 484: 345-59. 
(DOI: 10.1007/978-1-59745-398-1_23, PMID: 18592191) 
 
Barsnes H, Vizcaíno JA, Reisinger F, Eidhammer I and Martens L:  
Submitting proteomics data to PRIDE using PRIDE Converter 
Methods Mol Biol. 2010, Bioinformatics for Comparative Proteomics (in press) 
 
Barsnes H, Huber S, Sickmann A, Eidhammer I and Martens L:  
OMSSA Parser: An open-source library to parse and extract data  
from OMSSA MS/MS search results 
Proteomics 2009; 9(14): 3772-3774. 
(DOI:10.1002/pmic.200900037, PMID: 19639591) 
 
Muth T, Vaudel M, Barsnes H, Martens L and Sickmann A:  
XTandem Parser: An open-source library to parse and analyse  
X!Tandem MS/MS search results 
Proteomics 2010; 10(7): 1522-4. 
(DOI: 10.1002/pmic.200900759, PMID: 20140905) 
 
Helsens K, Colaert N, Barsnes H, Muth T, Flikka K, Staes A, Timmerman E, 
Wortelkamp S, Sickmann A, Vandekerckhove J, Gevaert K and Martens L:  
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ms_lims, a simple yet powerful open source LIMS for mass  
spectrometry-driven proteomics 
Proteomics 2010; 10(6): 1261-4. 
(DOI: 10.1002/pmic.200900409, PMID: 20058248) 
 
Vizcaino JA, Côté R, Reisinger F, Barsnes H, Foster JM, Rameseder J, Hermjakob H 
and Martens L:  
The Proteomics Identifications database: 2010 update 
Nucleic Acids Res. 2010 Jan;38(Database issue):D736-42 
(DOI: 10.1093/nar/gkp964, PMID: 19906717) 
 
Eisenacher M, Martens L, Hardt T, Kohl M, Barsnes H, Helsens K, Häkkinen J, 
Levander F, Aebersold R, Vandekerckhove J, Dunn MJ, Lisacek F, Siepen JA, 
Hubbard SJ, Binz PA, Blüggel M, Thiele H, Cottrell J, Meyer HE, Apweiler R and 
Stephan C:  
Getting a grip on proteomics data – Proteomics Data Collection (ProDaC)  
Proteomics 2009; 9(15): 3928-33. 
(DOI:10.1002/pmic.200900247, PMID: 19637238) 
 
Eisenacher M, Kohl M, Martens L, Barsnes H, Hardt T, Levander F, Häkkinen J, 
Apweiler R, Meyer HE and Stephan C:  
Proteomics Data Collection – 4th ProDaC Workshop on August 15th, 2008 in 
Amsterdam, The Netherlands 
Proteomics 2009; 9(2): 218-222.  
(DOI: 10.1002/pmic.200800732, PMID: 19105180) 
 
Eisenacher M, Martens L, Barsnes H, Hardt T, Kohl M, Häkkinen J, Apweiler R, 
Meyer HE and Stephan C:  
Proteomics Data Collection - 5th ProDaC Workshop 4 March 2009, Kolympari, 
Crete, Greece 
Proteomics 2009; 9(14): 3626-3629.  
(DOI:10.1002/pmic.200900205, PMID: 19639582) 
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4.2 Web Resources 
An important part in almost any tool development these days is creating a good web 
site for the tool. Ideally this site has to function at many levels and cater to many 
different types of users. First and foremost it has the important job of making the 
tool easily available for anybody who wants to download and use the tool. Secondly, 
it should also include additional information about the tool, most importantly how to 
use the tool: help on installing, tutorials, troubleshooting sections for common issues, 
how to upgrade the tool, etc.  
If appropriate the site should also include information about how to reuse (parts of) 
the tool in other settings, e.g., how to use the OLS Dialog in other projects. Finally, as 
often as possible the (well-documented) source code also ought to be made 
available. This ensures that all the efforts that went into the making of a tool can be 
tapped into by other developers, making it unnecessary to reinvent the same feature 
whenever needed. A good example is the spectrum viewer that is used in many of the 
tools, from OMSSA Parser to Fragmentation Analyzer. 
Having the required content is of course the key element of a web site. However, in 
addition the site ought to be well-structured and easy to navigate. This makes it 
possible for a site to contain large amounts of information tailored at different types 
of users without getting cluttered. Using the Google Code setup 
(http://code.google.com) ensures that a lot of the above points are implicitly taken 
care of. And with an additional effort, simple, organized and aesthetically pleasing 
web sites can easily be created for most tools. Google Code also supports open-
source development by providing an open-access version control archive for each 
project. 
Below is a list of web resources developed in relation to work described in this thesis. 
As far as possible they all try to implement the requirements just described. 
 
Fragmentation Analyzer:  http://fragmentation-analyzer.googlecode.com  
PRIDE Converter:   http://pride-converter.googlecode.com 
OLS Dialog:    http://ols-dialog.googlecode.com 
OMSSA Parser:    http://omssa-parser.googlecode.com 
XTandemParser:   http://xtandem-parser.googlecode.com 
MassShiftFinder:   http://www.bioinfo.no/software/massShiftFinder 
MassSorter:    http://www.bioinfo.no/software/massSorter 
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5 Discussion and Future Directions 
An important part of this thesis has been the development of several bioinformatics 
tools enabling and empowering users lacking a background in informatics to perform 
analyses and achieve results that would otherwise have been very difficult, e.g., 
converting proteomics data files with PRIDE Converter or analyzing fragmentation 
data with Fragmentation Analyzer. The amount of work that goes into this type of 
development is somewhat difficult to highlight in scientific publications, which of 
course mainly focus on the use of the tools and especially on the results achieved. 
This chapter will therefore underline the details not included in the publications, and 
discuss why the implementation of such tools is important for the proteomics 
community. Finally, some thoughts about future directions of proteomics will be 
given, with a focus on how these changes will affect research described in this thesis. 
 
5.1 User Interface Design 
The user interface is an essential part of any interactive program. User interfaces can 
be designed in many ways and there are no absolute measurements that can be used 
to classify one interface as better than another, and in many cases two or more very 
dissimilar interfaces might do the job. Different users may also prefer different 
interfaces. To deal with these issues, theories for designing good user interfaces have 
been developed. The theory presented in this section is mainly based on 
(Shneiderman, 1998), where eight golden rules of user interface design are described: 
1. Strive for consistency. 
2. Enable frequent users to use shortcuts. 
3. Offer informative feedback. 
4. Design dialogs to yield closure. 
5. Offer prevention and simple error handling. 
6. Permit easy reversal of actions. 
7. Make users the initiators of actions rather than the responders to actions. 
8. Reduce short-term memory load. 
These underlying principles have to be interpreted, refined and extended for each 
environment, but if used correctly they constitute a good foundation for the 
development of the user interface. In addition the interface has to consider what the 
users want to achieve through the software and make sure that the most common 
features are easily accessible. 
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User interfaces can be divided into two groups: (i) command-based interfaces; and (ii) 
interfaces based on direct manipulation. In command-based interfaces the user 
typically communicates with the system through written commands, and all 
commands must comply with the syntax rules determined by the programmer. In 
interfaces using direct manipulation however, the user interacts with the information 
presented by the program, e.g., by selecting from menus, clicking on buttons or 
entering text in forms.  
Both types of interfaces have their advantages. A command-based system is usually 
faster and more adaptable to advanced users’ needs, but the downside is that the 
user has to learn and remember the syntax of the commands. Interfaces using direct 
manipulation are typically easier to use for new or infrequent users and the features 
of the program are more visible to the user, i.e., the features are presented on screen 
and not hidden in a possibly unknown command. A weakness of direct manipulation 
is that experienced/frequent users may find it slow and less adaptable to their needs. 
This weakness can be mitigated by adding so-called short-cuts for experienced users, 
resulting in a combination of the advantages of direct manipulation with the 
advantages of command based interfaces. 
Even when a lot of effort is put into making an interface as easy to use as possible, 
errors will most likely still occur. There are generally two types that can occur when 
running a computer program: (i) program errors, i.e., errors in the source code; and 
(ii) user errors. Preventing errors from occurring is essential, but is not always easy. 
While the programmer has complete control over the source code, the same cannot 
be said about the user. Errors in the source code can, and should, be limited to a 
minimum, and most programming languages have tools for catching such errors if 
they do occur. The programmer can then display a message to the user explaining 
what went wrong. This approach can also be employed for user errors: allowing the 
user to make a mistake and tell him/her about it afterwards. However, a better 
approach is to prevent the user from making the mistake in the first place, e.g., 
instead of allowing the user to enter a date, make him/her select the date from a 
calendar. User errors can be labeled as either technical errors, e.g., clicking the wrong 
button by mistake, or logical errors, e.g., intentionally clicking the wrong button 
thinking it was correct. A good interface should try to limit both types of errors.  
Another way of reducing user errors is to include help facilities and tutorials covering 
the main features of the tool. Instead of trial and error, the user can then peruse the 
help and tutorial materials before trying. This will decrease the number of errors, and 
if an error should occur the user has somewhere to look for an explanation. However, 
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the user cannot be expected to figure out the reasons for all errors. Catching and 
storing error messages (e.g., in a log file) is therefore important, and can substantially 
help reduce the time required to locate the cause of a (user-)detected bug. This 
feature is implemented in most of the tools described in this thesis and has proven 
very to be useful in practice. 
Even after applying all the guidelines and theory above, a user interface may still 
contain issues, and an interface that is intuitive for the developer may not be intuitive 
for the user. All interfaces should therefore undergo thorough testing from real users 
and feedback from this process should be incorporated into the next release of the 
tool. For this to work, one should release often. As an example, see the release 
schedule of PRIDE Converter (see Chapter 2.5) included in the release notes found at 
the project’s home page [http://pride-converter.googlecode.com], where new 
versions are released frequently, sometimes just days apart. Frequent releases are 
especially important in the early development stages where the main features of the 
tools are fine tuned. It is also important to notify users of the availability of a new 
version, something which is done automatically at start-up in tools like PRIDE 
Converter. 
 
5.2 Enabling and Empowering Users 
Almost all research performed in the field of molecular biology today to some extent 
relies on the use of bioinformatics, e.g., the identification of proteins using sequence 
databases or the image analysis of microarrays and 2D gels. The main reason for 
using bioinformatics is the increasing complexity and size of the obtained data sets, 
giving computers a significant advantage in processing time and processing accuracy 
compared to the human brain, in many cases even making the analyses virtually 
impossible without the use of computers. However, it is still essential that the users 
understand both the data obtained and the key details of the (bioinformatics) 
analysis performed, including its strengths and weaknesses. Otherwise tools may be 
misused and/or the results incorrectly interpreted, e.g., being able to obtain a list of 
protein identifications from a given sample using a search algorithm on the one hand, 
and understanding the properties of the identifications (regarding statistical scores 
etc) on the other hand is not necessarily the same thing. 
One of the main advantages conveyed by good bioinformatics tools is that they 
enable the researchers who are closest to the data to perform the computational 
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analysis, rather than an external computationally oriented person, thus improving the 
quality of the research itself and the confidence in the achieved results. Using such 
tools results in more time for doing research, by reducing the time spent on manual 
calculations and comparisons etc. One example is the implementation of MassSorter 
(see Chapter 2.1) for comparing PMF data from multiple experiments. By using 
MassSorter this task can be performed in a matter of seconds, compared to hours or 
maybe days of work for manual inspection. In addition, the tool also provides better 
visualization of the results and supports further analyses. 
Bioinformatics tools also empower researchers without local bioinformatics support 
to explore their data more easily. One example is the use of Fragmentation Analyzer 
(see Chapter 2.4) to analyze large amounts of peptide identifications in a database, 
an analysis that would otherwise be difficult to carry out for many labs, even when 
the data are easily available. 
Moving the computational analysis closer to the (wet-lab) research also has 
additional advantages in that it makes it simpler to use the results of the analysis to 
design new experiments. This is especially important when doing “low-throughput” 
proteomics in which a smaller set of proteins (or a single protein) is analyzed for 
characterization purposes, e.g., to identify post-translational modifications. 
11
 Being 
able to quickly analyze the data and use the results to propose new experiments is 
essential in such focused settings. 
 
5.2.1 Converting and Annotating Data 
There are many formats used for storing proteomics data, and when submitting data 
to a repository these have to be converted to the format(s) supported by the 
repository. This conversion is not always straightforward and good tools are needed 
to simplify the process. In the following the implementation of PRIDE Converter and 
OLS Dialog (see Chapter 2.5) will be sketched, with a focus on how they simplify the 
conversion and annotation process. 
A wizard-like graphical user interface was chosen for PRIDE Converter. This makes it 
easy to get data from the user and simplifies the process by dividing it into smaller 
distinct steps. Using a wizard-like graphical user interface also has the advantage that 
it is familiar to most users, e.g., wizards are used when installing new programs. 
                                                           
11
 “Low-throughput” proteomics is here used as opposed to “high-throughout” proteomics which 
focuses on the rapid analysis (usually identification) of a large set of peptides or proteins. 
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PRIDE Converter starts with the selection of the data format to be converted, 
followed by eight simple steps; from the selection of the files to be converted; via the 
annotation of the experiment, instrument and protocol etc; through to the setting of 
the output details and the actual conversion. 
12
 Each step handles the 
description/annotation of one aspect of the data, thus resulting in a simplified 
conversion process. One can go back and forth between the steps to alter inserted 
information, and multiple files can be created by repeating (some of) the steps. All 
user-inserted information is stored for reuse, which greatly reduces the time required 
for subsequent conversions. 
13
 
During the conversion the tool interacts with the user, most importantly for the 
mapping of detected post-translational modifications to their corresponding 
controlled vocabulary PSI-MOD modifications (Montecchi-Palazzi, et al., 2008). The 
most common modifications are already mapped, but the user is requested to verify 
the (first occurrence of a) mapping due to the mappings not necessarily being unique, 
e.g., C* might mean different things for different data files. 
The PRIDE XML file created by the tool includes the required details from the data 
files, i.e., the spectra and the identifications, combined with the user input provided 
at the different steps, and is automatically validated and therefore ready for 
submission to PRIDE. Note that even though the result is an XML file, the user is not 
required to know anything about XML. The same is true for the data files used as 
input, i.e., no detailed knowledge about any of these data formats is expected either. 
Being able to easily convert data files is an important improvement, but the data 
should also be annotated using controlled vocabulary (CV) terms (see Chapter 
1.5.2.1). For this purpose the OLS Dialog was created (see Chapter 2.5). It provides a 
simply way of locating CV terms to annotate data, without requiring any knowledge 
about web services or ontology formats. Using the OLS Dialog inside PRIDE Converter 
provides a simple way of making sure that the data is annotated using terms that are 
immediately meaningful and searchable by others, thereby increasing the value of 
the submitted data. 
PRIDE Converter and OLS Dialog have been under continuous development, and the 
users’ informative feedback and requests for new features have been an important 
part of this process. As a result, PRIDE Converter has rapidly taken over as the main 
                                                           
12
  The steps supported do to some extent depend on the data format being converted. 
13
  For some data formats, part of the information to be annotated is included in the data files, and in 
these cases it is automatically extracted from the data files and presented to the user for verification. 
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tool used for preparing files for submission to PRIDE, see Figure 6, and in most cases 
the files are submitted without the need for support from the PRIDE team at the 
European Bioinformatics Institute (EBI) [www.ebi.ac.uk/pride].  
 
5.2.2 Analyzing Complex Data Sets 
Over time a proteomics lab produces large amounts of data, which could be a 
valuable source of information. However, these data must therefore be stored and 
annotated in ways that make such further analysis possible. Using a laboratory 
information management system (LIMS), usually built around a relational database, is 
in most cases the best option. In the following the focus will be on one such system 
called ms_lims (Helsens, et al., 2010), and how the information contained in this 
database can be easily analyzed using Fragmentation Analyzer (see Chapter 2.4). 
The goal of Fragmentation Analyzer is to extend and improve the understanding of 
the fragmentation 
 
 
Figure 6: An overview of the number of PRIDE experiments submitted each month, from 
September 2008 through to December 2009. The numbers are annotated by the conversion tool 
used, as ‘PRIDE Converter’ or ‘Others Methods’. Note that all the experiments submitted by other 
methods during November 2009 came from two projects, both submitted via MASPECTRAS 
(Hartler, et al., 2007) which has a built-in PRIDE export function. 
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the fragmentation of peptides into fragment ions, and the input consists of all the 
annotated fragment ions from the ms_lims database at Ghent University, Belgium, 
including the identified peptide sequences and the complete fragmentation spectra. 
In the database the desired data is spread over multiple tables, with some of these 
containing tens of millions of rows.  
This means that just extracting the required data for analysis already presents a 
substantial challenge. In addition, the data comes from various instruments, the 
identified peptides have different precursor charges, and some of the peptides are 
modified and some are not. All of these categories might have to be analyzed 
separately, providing a further data retrieval challenge.  
Fragmentation Analyzer makes it easy to extract the information from the database 
and to do the specialized analysis using a user-friendly graphical user interface. The 
tool enables the user to perform such analysis without any knowledge about the 
database structure or how the information is stored locally. It provides the users with 
easy access to the data, and with simple but efficient tools for analyzing parts of the 
results separately, e.g., analyze all peptide identifications from a given instrument 
where the peptides include a given modification. Performing such analyses is in fact 
quite difficult when performed by querying the database directly. 
Once the desired data is obtained, the next step consists of performing the analysis. 
Fragmentation Analyzer supports seven analysis types, which together make it 
possible to obtain novel information about the data that in many cases would not 
have been possible to achieve from single experiments. In most cases the results are 
visualized in interactive plots, which the user can alter as required, e.g., by removing 
data series or by zooming in on interesting areas. 
Fragmentation Analyzer thus enables the users to perform quite advanced analyses 
on complex data sets without the need for additional bioinformatics support. This 
makes it possible for even small labs to achieve results that would not otherwise have 
been possible, and serves as a good example of the importance of high-quality, user-
friendly bioinformatics tools. 
 
5.3 Open Source Software 
Open access publications are becoming increasingly more common in the scientific 
community and the advantages of this practice are obvious; information becomes 
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more easily accessible, hopefully resulting in better research across the scientific 
community. The same principles can also be applied to open access code, often 
referred to as open source software. Depending on the software license used, open 
source software permits users to use, change, and improve the software, and to 
redistribute it in modified or unmodified forms. In most cases all that is needed is to 
include the original license in the new software, similar to science in general where 
existing knowledge can be built upon and reused as long as the original research is 
referenced. 
Open source software has its challenges, perhaps chiefly the difficulty in making a 
profit from software that is open access, allowing everybody (at least in theory) to 
build and distribute their own versions. In many cases this problem is solved by 
relying on a business model where the code may be freely available, but users are 
instead charged for support and consultancy. For most software developed in 
research projects however, making a profit is never the main goal and in most cases 
the achievable profit is insignificant anyway.  
One example of open source software in the scientific community is the 
implementation of various statistical analysis methods, which is needed in most types 
of tools analyzing bioinformatics data. Instead of every project implementing its own 
version of the required analysis type, the analysis ought to be implemented in 
general open source libraries. Many such libraries have been created, e.g., R 
[http://www.r-project.org] and JFreeChart [http://www.jgoodies.com], which 
dramatically reduces the work required to implement and use a large variety of 
statistical methods and plotting the results of the analysis. 
Making the source code publicly available also has the benefit that it becomes much 
easier for others to participate in the development of the tool, and instead of getting 
a bug report the person detecting a bug could ideally also fix the bug. Adding new 
components or features and making the tool work in new settings also becomes 
much simpler when the source code is available. 
However, making a project open source requires an additional effort from the 
developers. The code ought to be well-structured, well-documented, easy to 
maintain and easy to understand by others. In some cases this non-trivial additional 
workload might result in projects not becoming open source, so a stronger incentive 
is sometimes needed. Some scientific journals recommend that projects are made 
open source when publishing, but very few are demanding open source. Given the 
additional benefits that open source projects provide (compared to closed-source 
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projects), this recommendation should be implemented by all journals publishing 
manuscripts describing tools, algorithms and methods, and perhaps changed from a 
recommendation to a strong request. This would result in more open source projects 
being published and each paper would contribute more to the community. In 
addition, this would reduce the problem of the variable lifespan of academic projects, 
which in many cases are left to die as soon as the people responsible move on to new 
projects or new jobs. Open source projects can live on even long after the original 
developers have left the project, thereby increasing the value of the developed tools 
beyond their immediate purpose. 
Open source software can to some extent be compared to the publishing of 
proteomics data. While publishing protein/peptide identifications alone can be 
useful, a lot more information is included when also publishing the mass spectra. 
Similarly for software, while publishing the results of the software and the software 
itself is valuable, the value increases substantially if in addition the source is made 
available. 
 
5.4 Future Directions 
In the world of science nothing is written in stone and future developments will most 
likely change many of our conceptions on how proteomics ought to be done, and new 
and possibly surprising pieces in the bigger puzzle of molecular biology will almost 
certainly be found. This section outlines some relevant future directions of 
proteomics, and discusses how this may influence the field. 
 
5.4.1 Standardized and Open Access Proteomics 
The work of standardizing proteomics, and in addition making sure that proteomics 
data are made publicly available, is perhaps the most important topic in proteomics 
today. As soon as standards for proteomics data have been implemented in all the 
instrument software and tools, and are in everyday use by researchers, the field of 
proteomics will change considerably. This will of course not happen overnight, but a 
widespread adoption of the standards within a couple of years should not be 
considered overly optimistic. In this setting, much of the work today spent on 
converting data or trying to understand an unknown data format can rather be spent 
doing actual research.  
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Mandatory submission of data to public repositories will also become much simpler, 
given that the data does not have to be converted as this will already be a part of the 
process in creating the data files. As a consequence the amount of data in public 
repositories will increase and enable the extraction of new knowledge from the 
accumulated data, which otherwise would have been out of reach. To make this 
possible the data have to be annotated by controlled vocabulary terms, and this is 
where tools such as the OLS Dialog can be utilized, see Chapter 2.5. 
Standardization will also free up a lot of programming time currently spent on 
repeating similar types of analysis for different instruments or data types. Instead the 
efforts can be directed at research-oriented tools trying to extract statistics-based 
knowledge from all available data. One example here would be a connection 
between the Fragmentation Analyzer and the PRIDE database, making it possible to 
analyze all data in PRIDE simultaneously. This could for example be used to analyze 
differences due to using different search algorithms, instruments or protocols, or to 
compare spectra and identifications to assess false positives. 
 
5.4.2 Improved Protein Quantification 
The field of protein quantification is rapidly maturing and the techniques employed 
are constantly improving. In the not too distant future protein quantification will 
hopefully become a technique that can be relied upon and trusted with even more 
confidence. This will open up a whole new vista of opportunities for innovative and 
interesting research. Improved techniques for protein quantification can also be 
connected with one of the most prominent buzz words in molecular biology today: 
biomarkers. Biomarkers are defined as characteristic biological properties that can be 
detected and measured, most often in blood, urine or tissue, to indicate something 
about the state of the cell or organism, e.g., if the individual is affected by a certain 
disease or not (Rosner, 2009). 
While biomarkers have been a catchphrase in the research community for some time 
the applicable results of the research are lagging behind and very few biomarkers 
have made it past the pre-clinical test stage, see for example (Taube, 2009). Improved 
techniques for measuring and quantifying proteins might just be the break-through 
that the field is waiting for. 
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5.4.3 Integrative Omics Research 
The ultimate goal of biological research is of course to put everything together and 
reveal the bigger picture. This cannot be achieved by proteomics alone. Only by 
combining and integrating results from many of the distinct omics fields can this be 
accomplished. For example by combining genome data with transcriptomes 
14
 (from 
microarrays or next-generation sequencing) and quantitative proteomics data, novel 
and exciting results might be obtained. Most of these results would not have been 
possible by using just one of the data types. Examples of integrative omics 
approaches are given in (Thongboonkerd, 2005) and (Fukushima, et al., 2009). 
Effective integrative omics research relies on a high level of maturity in all the 
relevant omics fields. The standardization activities that proteomics is currently 
undergoing are thus an essential contribution in preparing the field for the next 
generation integrative omics research. Exciting new opportunities for research will 
therefore certainly become available in the foreseeable future, through hard work 
and perhaps also a little serendipity. 
  
                                                           
14
  The transcriptome is the set of all RNA molecules, including mRNA, rRNA, tRNA, and non-coding 
RNA produced in one or a population of cells. 
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